Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
* Clover's vaccine will test GSK, Dynavax boosters in 150 adults* Builds on earlier collaborations with the UK, U.S. drugmakers* Initial data from study expected in August (Adds context on China, Dynavax and GSK efforts)June 19 (Reuters) - Clover ...
Read more
GlaxoSmithKline To Raise New Funds Through Issue Of Senior Notes
Read more
(Sharecast News) - Berlin unveiled a multi-million dollar investment into German biotechnology outfit CureVac, alongside dievini Hopp BioTech, SAP co-founder Dietmar Hopp's holding company.
Read moreGlaxo And Pfizer's ViiV Gets US FDA Approval For Tivicay PD Tablets
Read more(Sharecast News) - Senior scientists have reported flaws in an influential World Health Organization-commissioned study into the risks of coronavirus infection and say it should not be used as evidence for relaxing the UK's 2-metre physical distancing rule. Critics of the distancing advice, which states that people should keep at least 2 metres apart, believe it is too cautious. They seized on the research commissioned by the WHO, which suggested a reduction from 2 metres to 1 would raise infection risk only marginally, from 1.3% to 2.6%. - Guardian
Read moreJune 12 (Reuters) - The U.S. Food and Drug Administration has approved a drug to treat infants and children with HIV, with the drug having been developed by drugmaker GlaxoSmithKline's HIV drugs division ViiV Healthcare, the FDA and the GSK unit ...
Read moreLONDON, June 10 (Reuters) - Two drugs used to treat inflammatory diseases and cancer are being tested as potential therapies for patients with COVID-19, the Universities of Birmingham and Oxford announced on Wednesday.Severe cases of COVID-19 are ...
Read moreFRANKFURT, June 9 (Reuters) - GlaxoSmithKline (GSK) has started a trial in the United States to test an experimental rheumatoid arthritis drug on patients suffering from pneumonia caused by COVID-19, the British drugmaker said on Tuesday.The compa...
Read moreBy Ludwig BurgerFRANKFURT, June 5 (Reuters) - AstraZeneca's cancer drug Calquence has shown initial signs of helping hospitalised COVID-19 patients get through the worst of the disease, as researchers scramble to repurpose existing treatments to h...
Read more(Sharecast News) - Pharmaceutical company GlaxoSmithKline announced it will produce 1bn doses of coronavirus vaccine booster in preparation for an eventual immunisation drive.
Read more(For a live blog on European stocks, type LIVE/ in an Eikon news window)* Cineworld soars on cash boost, targets July reopening* Defensive sectors lead late rally in Europe* Markets ignore U.S.-China tensions for now (Updates to market close)By Sru...
Read more* Cineworld among top FTMC performers on plans for July reopening* AstraZeneca up 4.4% after outlining COVID-19 treatment trials* GSK up 2% on plans for vaccine booster production (Adds details, updates to close)By Sagarika Jaisinghani and Ambar W...
Read more* Expects to make 1 bln doses of vaccine adjuvant in 2021* In talks for production funding and expansion* Shares up 1.4% on FTSE 100* For a FACTBOX on COVID-19 drug development, see: (Adds details on global vaccine approaches, GSK's vaccine adjuvan...
Read more* Expects to make 1 bln doses of vaccine adjuvant in 2021* Says more than one COVID vaccine needed globally* In talks for production funding and expansion (Adds detail on COVID vaccines, GSK executive comment)May 28 (Reuters) - Britain's GlaxoSmithK...
Read more(Sharecast News) - Sanofi will sell its stake in US-based maker of Covid-19 treatments Regeneron Pharmaceuticals.
Read more
Last checked at